Date published: 2026-1-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

Int-6 Inhibitors

Int-6 (Integration site 6) inhibitors are a class of chemical compounds that primarily target a cellular protein known as Int6 or eIF3e (eukaryotic translation initiation factor 3e). Int6 is a subunit of the eukaryotic translation initiation factor eIF3, which plays a crucial role in protein synthesis, a fundamental cellular process essential for the growth and maintenance of all living organisms. Inhibitors of Int6 function by disrupting its normal activities within the eIF3 complex, leading to significant consequences for cellular protein synthesis regulation and potentially impacting various cellular functions.

The eIF3 complex, in which Int6 is a subunit, is involved in several key steps of translation initiation, including the recruitment of the ribosome to the mRNA (messenger RNA) and the scanning of the ribosome along the mRNA to identify the start codon. Int6, as a part of this complex, contributes to the proper assembly and function of eIF3 during translation initiation. Inhibitors of Int6 are designed to interfere with these functions, either by directly binding to Int6 or by affecting its interaction with other components of the eIF3 complex. This disruption can lead to dysregulated protein synthesis, potentially causing a global impact on cellular protein production, which in turn can influence various cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Crosslinks with DNA, causing DNA damage and inhibiting cell division in rapidly dividing cells.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Targets and inhibits specific tyrosine kinases, such as BCR-ABL, involved in the growth of cancer cells.

Tamoxifen

10540-29-1sc-208414
2.5 g
$272.00
18
(2)

Competes with estrogen for binding to estrogen receptors in breast tissue, blocking estrogen's growth-promoting effects.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits multiple kinases involved in tumor cell proliferation and angiogenesis, disrupting cancer growth pathways.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Inhibits the proteasome, preventing the degradation of proteins that regulate cell cycle and apoptosis in cancer cells.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

Inhibits mTOR kinase, reducing cell growth, proliferation, and angiogenesis in cancer cells.

Vemurafenib

918504-65-1sc-364643
sc-364643A
10 mg
50 mg
$117.00
$423.00
11
(1)

Targets mutated BRAF kinases in melanoma, inhibiting the MAPK pathway, which drives tumor growth in melanoma.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Blocks EGFR tyrosine kinase activity, disrupting signaling pathways involved in lung cancer cell growth.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Inhibits JAK1 and JAK2 kinases, reducing inflammation and abnormal cell proliferation in conditions like myelofibrosis.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

Traps PARP enzymes at DNA damage sites, preventing DNA repair in cancer cells with defective BRCA genes.